# Metacare

Metacare is a Corporate Investor based in Hwaseong-si, South Korea.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Hwaseong-si, South Korea
- **Region:** Asia
- **Address:** Hwaseong-si, Gyeonggi-do, South Korea
- **Founded:** 2009
- **Assets under management:** Undisclosed
- **Website:** meta-care.co.kr
- **LinkedIn:** https://www.linkedin.com/company/metacare

## Regulatory record

- **Reports private funds:** No

## About

Metacare originated in 2009 as Chorokbaem Healthcare, a diversification pivot for the Seoul-based Chorokbaem Group, a publicly listed entity historically known for K-drama production and media. Won Young-sik, the Group's Chairman, provides strategic direction, while Metalabs Co., Ltd. holds a controlling 33.21% equity stake, binding Metacare to the broader corporate ecosystem rather than operating as a standalone fund. The firm's investment strategy centers on direct buyouts within healthcare services and related real estate. Metacare owns the Jeju Hospital, a commercial medical facility on Jeju Island, and a commercial land and building property in Daegu. Its cross-border posture is visible in two hospital projects — one in China and one in India — signaling a willingness to export Korean healthcare operational models into high-growth Asian markets. The focus remains physical infrastructure and operating assets, not venture-stage therapeutics or medical devices. Metacare has not publicly disclosed its total assets under management; independent estimates place its balance-sheet scale at roughly $88 million (Altss estimate). The management structure is lean, with no separate investment professionals listed beyond the corporate parent's leadership. The firm's capital base is corporate-bankrolled rather than third-party institutional commitments, making it a captive allocator for Chorokbaem Group's off-media investments. Metacare's architecture is unusual — a corporate investor nested within a publicly traded media group, directing retained earnings into hard healthcare assets rather than financial-portfolio strategies. This hybrid structure gives it patient capital without LP redemption pressure, though it also ties its fate to the parent group's governance and the operational performance of a concentrated set of hospital properties.

## Sectors

- Healthcare Services
- Real Estate

## People

- Won Young-sik — Chairman of Chorokbaem Group

## Questions

### Who controls Metacare?

Metacare is majority-owned by Metalabs Co., Ltd., which holds approximately 33.21% of the equity, and is affiliated with Chorokbaem Group, a publicly traded South Korean company. Won Young-sik, the Group's Chairman, is the key principal associated with Metacare's strategic direction. The firm does not operate as an independent partnership with external limited partners.

### How is Metacare related to Chorokbaem Group?

Metacare was originally established as Chorokbaem Healthcare, a subsidiary designed to diversify the parent group beyond its core media business. The firm remains tightly linked to Chorokbaem through a cross-shareholding structure, with entities like Chorokbaem Media Co., Ltd. appearing as co-investors. It functions as the group's primary vehicle for healthcare and real-property investments.

### Does Metacare invest in venture-stage healthcare companies?

No. Metacare's publicly known assets are commercial real estate and operating hospitals, including properties in Daegu and Jeju and project-based hospital developments in China and India. The firm's strategy is classified as buyout-focused, with no disclosed activity in early-stage pharmaceutical or med-tech venture investing.

### Where does Metacare's investment capital come from?

Metacare's capital derives from the corporate treasury of the wider Chorokbaem Group and its major shareholders, such as Metalabs. It does not raise capital from third-party institutional limited partners or family offices. This structure makes it a captive corporate investor deploying group retained earnings rather than a traditional fund manager.

### What is the estimated investment scale of Metacare?

Metacare has not publicly disclosed any assets under management figure. Independent estimates place the firm's balance sheet at approximately $88 million, based on its known portfolio of commercial land, hospitals in Jeju and Daegu, and its cross-border project commitments (Altss estimate).

## Related profiles

- [Alexander and Margaret Stewart Trust](https://altss.com/profile/alexander-and-margaret-stewart-trust)
- [Karin Bain and John Kukral Foundation](https://altss.com/profile/karin-bain-and-john-kukral-foundation)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/metacare

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology